Table of Content

Executive Dashboard
Purpose of this Study
Methodology
5-step Process to Transformational Growth
Key Findings
Key Questions this Study will Answer
Market Engineering Measurements
Transformation in the Industry Ecosystem
Macro Trends—Biologics Discovery, Development and Manufacturing
Technology Trends—Biologics Discovery, Development and Manufacturing
5 Big Themes for the Global Biologics Market
Strategic Imperatives for the Biologics Market

Market Overview—Biologics
Scope
Market Segmentation
Description of Main Product Categories
Characteristics of Biologics
Lifecycle of Biologics Products
Market Drivers and Restraints

Market Dynamics
Key Biologics Companies
Biologics R&D Expenditure
Regulatory Framework for Biologics Approval
Region-wise Regulatory Drug Approval Trends
Key Issues in Market Entry for Regenerative Medicine

COVID-19 Impact Analysis on the Biologics Market
Top-level Impact of COVID-19 Pandemic on the Biologics Market
Biologics Manufacturing and Supply Line Challenges
Biologics Pipeline Targeting COVID-19 (SARS-COV-2)
Revenue Forecast—COVID-19 Impact Methodology
Growth Opportunities Critical for Future Success in a Post-pandemic Biologics Market
Companies to Action
Strategic Imperatives for Companies in Light of COVID-19

Revenue Forecast—Total Biologics Market
Methodology
Market Engineering Measurements
Revenue Forecast—Pre-COVID-19 vs. Post-COVID-19 Impact
Product Segmentation
Total Biologics Market—Top 10 Products
Breakdown by Therapeutic Area
Changing Dynamics
Percent Revenue Forecast by Product Type

Antibody Therapies Segment Analysis
Antibody Therapies—Overview of Top 10 Products
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Anticipated Key Product Launches
Changing Dynamics
Technology Trends in the Antibody Therapy Platform

Recombinant Proteins Segment Analysis
Recombinant Proteins—Overview of Top 10 Products
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Anticipated Key Product Launches
Changing Dynamics

Vaccines Segment Analysis
Vaccines—Overview of Top 10 Products
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Anticipated Key Product Launches
Changing Dynamics

Cell & Gene Therapy Segment Analysis
Cell & Gene Therapy—Overview of Top 10 Products
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Technology Trends in the Cell Therapy Platform
Anticipated Key Product Launches
Changing Dynamics
Technology Trends in RNA and Viral Vector Platforms

Companies to Action—Pipeline Analysis
Roche AG
AMGEN
Sanofi
AbbVie
Novo Nordisk
Merck
Pfizer
Johnson & Johnson
Eli Lilly
GlaxoSmithKline

Growth Opportunities
Major Growth Opportunities
Growth Opportunity 1—ADCs/Polyclonal Antibodies
The Future Trends in Antibody Therapy
ADC Pipeline Analysis
ADCs—Need for Outsourcing
Bio-CDMO Benchmarking—ADC Development and Manufacturing Services
Growth Opportunity 2—RNA-based Therapies & Vaccines
Strategic Imperatives for Better Vaccines
RNA Therapy Pipeline Analysis and Industry Partnerships
mRNA Technology set to Revolutionize Vaccine Therapies
Growth Opportunity 3—Gene Therapy Advancements
Investments & Partnerships Advancing CRISPR/Cas Gene Editing Technology
Gene Therapy—Collaborations and Partnerships
CDMOs to Drive the Growth of Gene Therapy
Growth Opportunity Matrix

The Last Word—Strategic Considerations for Staying on the Growth Trajectory
Top 3 Predictions for the Market
Legal Disclaimer

Appendix
Market Engineering Methodology
List of Key Companies Included in this Research Service
List of Exhibits
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)